The U.S. Diabetes Prevention Program, or DPP, reported on April 28 the 21-year follow-up of a randomized clinical trial, showing that the original intensive lifestyle intervention reduced the development of diabetes by 24% and metformin reduced diabetes development by 17%.
Both lifestyle and metformin interventions show long-term benefits in reducing type 2 diabetes
